TOXICOLOGY AND APPLIED PHARMACOLOGY, published by Academic Press, Inc. Elsevier Science, stands as a leading journal in the domains of toxicology and pharmacology, with its establishment dating back to 1959. With an impact factor reflecting its academic rigor and relevance, this journal is classified in the Q2 quartile for both pharmacology and toxicology categories, underscoring its significance in the scientific community. It ranks #34 out of 133 in Toxicology and #95 out of 313 in Pharmacology according to Scopus, placing it within the 74th and 69th percentiles, respectively. The journal aims to disseminate quality research that drives advancements in understanding the interactions of drugs and toxic substances within biological systems. Researchers and professionals are invited to contribute and engage with a broad spectrum of articles that cover mechanistic studies, risk assessment, and innovative therapeutic strategies. Although the journal does not offer open access, it continues to be a crucial resource for those who seek to navigate the complex interface of drugs and their toxicological implications.

NEUROTOXICOLOGY, published by Elsevier, stands at the forefront of research in the disciplines of neuroscience and toxicology, contributing significantly to the understanding of neurotoxic effects and their implications for health. With an impact factor positioned within the second quartile in both neuroscience and toxicology categories, this journal has established itself as a crucial platform for disseminating high-quality research findings and innovative methodologies. Since its inception in 1979 and continuing through 2024, NEUROTOXICOLOGY has provided valuable insights and evidence-based studies that facilitate advancements in the fields of pharmacology and neuroscience, making it a pivotal resource for researchers, professionals, and students alike. Although not an open-access publication, it offers extensive access options ensuring wide dissemination of knowledge. Located in the Netherlands, the journal’s continued commitment to excellence is evident through its high rankings in Scopus, reflecting its prominence and relevance in the scientific community.

CHEMICO-BIOLOGICAL INTERACTIONS is a premier journal published by Elsevier Ireland Ltd, dedicated to advancing the field of chemical and biological interactions since its inception in 1969. With a robust focus on pharmacology and toxicology, the journal holds a prestigious Q1 ranking in both Medicine (miscellaneous) and Toxicology, reflecting its significance in disseminating influential research. As part of the Scopus database, it ranks #21 out of 133 journals in Toxicology, positioning it in the 84th percentile and ensuring high visibility for cutting-edge studies. This scholarly platform serves as a crucial resource for researchers, professionals, and students who seek reliable and innovative findings at the intersection of chemistry and biology. While currently not open access, CHEMICO-BIOLOGICAL INTERACTIONS provides a comprehensive collection of articles that contribute to the ongoing dialogue in toxin research and its implications on medicinal chemistry, thereby fostering advancements in public health and safety.

Comparative Biochemistry and Physiology C-Toxicology & Pharmacology, published by Elsevier Science Inc, stands as a prominent resource in the fields of pharmacology, toxicology, and biochemical research. With its ISSN 1532-0456 and E-ISSN 1878-1659, this journal has carved out a significant niche, focusing on the comparative aspects of biochemical and physiological data across various species. Recognized for its impact in diverse fields, it boasts a Q1 ranking in Animal Science and Zoology, Aquatic Science, Health, Toxicology and Mutagenesis, alongside respectable standings in other related disciplines. Researchers and professionals can leverage this publication to access high-quality, peer-reviewed studies that advance the understanding of biochemical processes and their toxicological implications. The journal aims to bridge the gap between laboratory findings and real-world applications, fostering an environment for interdisciplinary collaboration. For academics seeking to enhance their knowledge or contribute to this impactful field, Comparative Biochemistry and Physiology C-Toxicology & Pharmacology serves as an invaluable platform.

JOURNAL OF APPLIED TOXICOLOGY, published by Wiley, stands as a leading platform in the field of toxicology, focusing on the rigorous examination of chemical substances and their effects on biological systems. With an impressive Impact Factor, it ranks in the top quartile (Q2) for toxicology journals, reflecting its esteemed position within the scientific community. The journal, identifiable by its ISSN 0260-437X and E-ISSN 1099-1263, has been an invaluable resource since its inception in 1981, and it continues to serve as a conduit for innovative research and practical applications through 2024. Positioned at the forefront of the field, it garners recognition in the Scopus Rankings, where it ranks #31 out of 133 journals in the toxicology category, placing it in the 77th percentile—a testament to its contribution to the advancement of pharmacology and toxicological sciences. While not an open-access journal, it remains accessible to a wide audience of researchers, professionals, and students eager to explore cutting-edge findings in applied toxicology, making it a pivotal resource for enhancing knowledge and fostering collaboration in the field.

Biochemistry Research International is a prominent and dynamic journal published by Hindawi Ltd, dedicated to advancing knowledge in the field of biochemistry. With its Open Access model established since 2010, the journal provides unrestricted access to high-quality research, thereby fostering global communication among researchers and professionals. Operating out of the United States, Biochemistry Research International serves as a vital platform for disseminating cutting-edge findings in biochemistry and molecular biology, holding a respectable Q2 ranking in its category as of 2023. The journal's scope encompasses a wide array of topics including but not limited to biochemical processes, genetic engineering, and molecular interactions, making it an essential resource for students and seasoned researchers alike. With an impact factor reflective of its significance in the academic community, Biochemistry Research International continues to play an integral role in shaping the future of biochemistry research.

ARCHIVES OF TOXICOLOGY is a prestigious journal published by Springer Heidelberg, dedicated to advancing research in the field of toxicology and related disciplines. With a distinguished history dating back to 1930, this journal has continuously provided vital insights and groundbreaking studies, making it a cornerstone in the areas of health, toxicology, and medicine. Recognized for its high impact, it occupies a top-ranking position in Scopus, with remarkable quartile placements in 2023, categorizing it as Q1 in Health, Toxicology and Mutagenesis, and Q1 in Medicine (Miscellaneous). The journal highlights critical research and innovative methodologies, appealing to a diverse audience of researchers, professionals, and students committed to understanding the complexities of toxic substances and their implications for public health and environmental safety. The journal does not currently offer open access, allowing for a more traditional but rigorous peer-review process that ensures the quality and integrity of every published article. Join the global discourse in toxicological science with ARCHIVES OF TOXICOLOGY, where every contribution furthers the understanding of safety and toxicity in our world.

TOXICOLOGY, published by Elsevier Ireland Ltd, is a prestigious peer-reviewed journal specializing in the field of toxicology. With an ISSN of 0300-483X and an E-ISSN of 1879-3185, this journal provides a vital platform for researchers, professionals, and students to disseminate and access groundbreaking studies from 1973 to present, with a convergence set until 2024. Recognized for its high impact, it holds a Q1 ranking in Toxicology category and ranks #18 out of 133 in Scopus's sector of Pharmacology, Toxicology, and Pharmaceutics, placing it in the 86th percentile. While the journal is not open access, it nonetheless offers a rich collection of research articles that enhance the understanding of toxicological science and its applications. The journal's objectives encompass advancing knowledge in the toxicological evaluation of substances, promoting safety in public health, and fostering dialogue among scholars. As a key resource in the field, TOXICOLOGY plays a crucial role in advancing research and informing practices related to toxicological risks and safety assessments.

Drug and Chemical Toxicology is a well-respected journal in the fields of toxicology, pharmacology, and public health, published by Taylor & Francis Ltd. Since its inception in 1978, this journal has diligently explored the effects and mechanisms of chemical exposures on health and the environment, fulfilling a crucial role in advancing scientific understanding and safeguarding public health. The journal is indexed across prestigious databases and features an impressive array of articles categorized within the Q2 and Q3 quartiles across various categories in 2023, reflecting its significance in Chemical Health and Safety as well as Environmental and Occupational Health disciplines. With an extensive reach and a focus on interdisciplinary research, Drug and Chemical Toxicology offers a rich repository of original research, reviews, and methodological advancements, catering to a diverse audience of researchers, professionals, and students dedicated to the betterment of safety and health standards. Although not an open-access publication, its articles are widely accessible to the academic community, ensuring that critical innovations and insights are shared for the greater good.

The European Journal of Pharmacology, a prestigious publication by Elsevier, serves as a vital resource in the field of pharmacology, offering rich insights into drug development and therapeutic applications. Since its inception in 1967, this journal has evolved to encompass groundbreaking research, including pharmacokinetics, toxicology, and innovative pharmacological methodologies, making it an essential platform for researchers and professionals alike. With an impressive impact factor that places it in the Q1 category of pharmacological journals and a Scopus ranking of #49 out of 313, the journal is recognized in the 84th percentile within its category, solidifying its significance in the academic community. Although the journal is not open access, it continues to attract contributions from leading scientists worldwide, ensuring that cutting-edge findings are disseminated effectively. The European Journal of Pharmacology not only highlights advancements in drug discovery and clinical applications but also promotes interdisciplinary collaboration, ultimately contributing to the progress of healthcare globally.